The Journal of Dual Diagnosis (JDD) includes articles and perspectives from four overarching domains relevant to the field: Psychopharmacology & Neurobiology; Psychotherapy & Psychosocial Issues; Services & Policy; and Clinical Forum. Consequently, each issue serves to encourage integration of these domains.
JDD publishes articles relevant to a comprehensive audience interested in dual diagnosis, including: researchers, physicians, and policy makers. High-quality empirical research, brief reports, timely reviews, thought-provoking commentaries, and ongoing discussions of clinical issues will be considered for publication, all with the aim of better understanding of the basis of, and optimal treatment for, co-occurring psychiatric and substance use disorders.
We publish papers covering the full spectrum of the field of dual diagnosis. Clinical, translational and basic science submissions are all welcome. Additionally, timely reviews, as well as submissions related to opioid use and the use of technology in dual diagnosis patients are of great interest to the journal.